Steris Corp (STE) Stock Price, Quote & News

Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in proced...

Industry: Medical Devices

Sector: Healthcare

Phone: 440 354 2600

Website: www.steris.com

Address:

5960 Heisley Road, Mentor, United States

ihuntbiggame Apr. 20 at 3:47 PM

$VUZI Connect more DOTS... Mr. YUTAKA, what a good looking suit & wish I still had all that hair! $HIMS? We can assume...these 3 dots are going to be released... MUFAM is a major institutional lender and investor in the pharmaceutical and medical equipment sectors. These companies use AR for remote surgical assistance, medical training, and pharmaceutical manufacturing quality control. Vertex Pharmaceuticals ($VRTX): MUFAM increased its stake in Vertex Pharmaceuticals to over 544,000 shares (valued at ~$213M) in early 2026. Vuzix tech is used in high-stakes biotech labs for hands-free data visualization during drug discovery and manufacturing processes. STERIS plc ($STE): MUFAM holds over 1.5M shares (~$387M) in STERIS, a leader in sterilization and surgical equipment. Smart glasses are used in sterile processing departments to provide step-by-step digital workflows for technicians cleaning complex surgical instruments.

2 · Reply

MonkeyPlanet Mar. 27 at 6:10 PM

$STE 🥰

0 · Reply

Ro_Patel Mar. 13 at 2:37 PM

CFRA initiates coverage on $STE & sets TP of $275

0 · Reply

Factozcentral Feb. 23 at 3:05 PM

$SPHR $STE $SSNC $STNG 👁️

0 · Reply

Estimize Feb. 19 at 9:00 PM

Wall St is expecting 2.85 EPS for $STE Q4 [Reporting 05/20 AMC] http://www.estimize.com/intro/ste?chart=historical&metric_name=eps&utm_cont

0 · Reply

ZacksResearch Feb. 5 at 3:01 PM

$STE’s earnings in line, but why the drop? 🤔 Q3 EPS met the Zacks Consensus Estimate at $2.53, with the revenue figure surpassing estimates by 1.1%. Yet, shares fell 3.6% post-earnings due to margin contraction concerns 📉. Complete risk/reward breakdown here 👉 https://www.zacks.com/stock/news/2829761/ste-q3-earnings-meet-revenues-beat-stock-dips-in-aftermarket-trading?cid=sm-stocktwits-2-2829761-body-32076&ADID=SYND_STOCKTWITS_TWEET_2_2829761_BODY_32076

0 · Reply

ZacksResearch Feb. 5 at 2:01 PM

$STE just beat revenues — and the stock still sold off. ⚠️ Q3 earnings met estimates and revenues came in ahead, but shares dipped in aftermarket trading as investors zeroed in on gross margin contraction despite solid growth. See what’s really driving the market’s reaction here 👉 https://www.zacks.com/stock/news/2829761/ste-q3-earnings-meet-revenues-beat-stock-dips-in-aftermarket-trading?cid=sm-stocktwits-2-2829761-teaser-32075&ADID=SYND_STOCKTWITS_TWEET_2_2829761_TEASER_32075

0 · Reply

StocktwitsEarnings Feb. 5 at 12:00 PM

$STE Q3 '26 Earnings Results & Recap For fiscal 2026, Steris Plc expects as reported revenue from continuing operations to increase 8-9%, with adjusted EPS ranging from $10.15 to $10.30, and free cash flow anticipated at $850M.

0 · Reply

ProtocolPartners Feb. 4 at 11:30 AM

$STE is a diversified healthcare product company; its procedure kit business provides steady recurring revenue.

0 · Reply

ZacksResearch Feb. 3 at 1:03 PM

Q4 earnings season is heating up — but the setup is tricky ⚠️📊 $BSX, $ALGN, $STE, and $TECH are set to report as sector profits slow, even while revenue growth stays steady — a classic margin-vs-growth tension to watch closely. See what this earnings setup could mean for these names 👉 https://www.zacks.com/stock/news/2827637/medtech-stocks-to-watch-for-earnings-on-feb-4-bsx-algn-more?cid=sm-stocktwits-2-2827637-teaser-31608&ADID=SYND_STOCKTWITS_TWEET_2_2827637_TEASER_31608

0 · Reply

STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026

Feb 4, 2026, 4:30 PM EST - 2 months ago

STERIS Announces Financial Results for Fiscal 2026 Third Quarter

Jan 28, 2026, 4:30 PM EST - 3 months ago

STERIS Announces Dividend of $0.63 per share

Jan 21, 2026, 4:30 PM EST - 3 months ago

STERIS to Host a Conference Call for Fiscal 2026 Third Quarter Results on February 5, 2026

Jan 20, 2026, 4:30 PM EST - 3 months ago

METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

MTD

Nov 5, 2025, 4:30 PM EST - 6 months ago

STERIS Announces Financial Results for Fiscal 2026 Second Quarter

Oct 21, 2025, 4:30 PM EDT - 6 months ago

STERIS to Host a Conference Call for Fiscal 2026 Second Quarter Results on November 6, 2025

Aug 6, 2025, 4:31 PM EDT - 9 months ago

STERIS Announces Chief Financial Officer Transition

Aug 6, 2025, 4:30 PM EDT - 9 months ago

STERIS Announces Financial Results for Fiscal 2026 First Quarter

Jul 30, 2025, 4:30 PM EDT - 9 months ago

STERIS Raises Dividend to $0.63 per share

Jul 22, 2025, 4:30 PM EDT - 9 months ago

STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025

May 20, 2025, 7:57 AM EDT - 1 year ago

U.S. Gynecological Chairs and Tables Market Size, Share & Trends Analysis Report 2025-2030 Featuring STERIS, The Brewer Company, Midmark Corp. (Ritter Midmark), Clinton Industries, UMF Medical and More

May 15, 2025, 12:39 PM EDT - 1 year ago

Why This Medical Equipment Stock Is Today's S&P 500 Winner

May 14, 2025, 5:26 PM EDT - 1 year ago

Steris forecasts annual profit above estimates on strong medical equipment sales

May 14, 2025, 5:06 PM EDT - 1 year ago

Steris Fiscal Fourth-Quarter 2025 Financial Results: Just the Numbers

May 14, 2025, 4:30 PM EDT - 1 year ago

STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year

May 7, 2025, 4:30 PM EDT - 1 year ago

STERIS Declares Dividend of $0.57 per share

Apr 22, 2025, 4:30 PM EDT - 1 year ago

STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025

Feb 5, 2025, 6:43 PM EST - 1 year ago

Steris lowers annual profit forecast due to a stronger dollar

Feb 5, 2025, 4:30 PM EST - 1 year ago

STERIS Announces Financial Results for Fiscal 2025 Third Quarter

Jan 22, 2025, 4:30 PM EST - 1 year ago

STERIS to Host a Conference Call for Fiscal 2025 Third Quarter Financial Results on February 6, 2025

Jan 21, 2025, 6:30 AM EST - 1 year ago

STERIS Announces Outcome of Ethylene Oxide Trial

Nov 6, 2024, 5:44 PM EST - 1 year ago

Steris beats quarterly estimates on continued demand for medical procedures

Nov 6, 2024, 4:30 PM EST - 1 year ago

STERIS Announces Financial Results for Fiscal 2025 Second Quarter

Oct 23, 2024, 4:30 PM EDT - 1 year ago

STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financial Results on November 7, 2024

Oct 9, 2024, 3:39 PM EDT - 1 year ago

STERIS plc (STE) Enters New $1.1 Billion Revolving Credit Agreement

Aug 26, 2024, 4:30 PM EDT - 1 year ago

STERIS to Present at the Morgan Stanley Healthcare Conference

Aug 6, 2024, 4:30 PM EDT - 1 year ago

STERIS Announces Financial Results for Fiscal 2025 First Quarter

Jul 31, 2024, 4:30 PM EDT - 1 year ago

STERIS Raises Dividend to $0.57 per share

Jul 23, 2024, 4:30 PM EDT - 1 year ago

STERIS to Host a Conference Call for Fiscal 2025 First Quarter Financial Results on August 7, 2024

Jun 3, 2024, 7:00 AM EDT - 2 years ago

PEAK ROCK CAPITAL AFFILIATE COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION OF HUFRIEDYGROUP

May 8, 2024, 4:30 PM EDT - 2 years ago

STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year

May 1, 2024, 4:30 PM EDT - 2 years ago

STERIS Announces Dividend of $0.52 per share

Apr 24, 2024, 4:30 PM EDT - 2 years ago

STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024

Apr 11, 2024, 7:30 AM EDT - 2 years ago

PEAK ROCK CAPITAL AFFILIATE SIGNS DEFINITIVE AGREEMENT TO ACQUIRE HUFRIEDYGROUP

Apr 11, 2024, 6:58 AM EDT - 2 years ago

STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital

Feb 7, 2024, 6:35 PM EST - 2 years ago

Steris beats third-quarter estimates on strong medical procedure demand

Feb 7, 2024, 4:30 PM EST - 2 years ago

STERIS Announces Financial Results for Fiscal 2024 Third Quarter

Jan 23, 2024, 4:30 PM EST - 2 years ago

STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024

Nov 7, 2023, 4:30 PM EST - 2 years ago

STERIS Announces Financial Results for Fiscal 2024 Second Quarter

Oct 24, 2023, 4:30 PM EDT - 2 years ago

STERIS to Host a Conference Call for Fiscal 2024 Second Quarter Financial Results on November 8, 2023

Aug 2, 2023, 4:30 PM EDT - 2 years ago

STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD

Aug 1, 2023, 5:39 PM EDT - 2 years ago

Medical device maker Steris lifts 2024 results view, records quarterly beat

Aug 1, 2023, 4:30 PM EDT - 2 years ago

STERIS Announces Financial Results for Fiscal 2024 First Quarter

Jul 26, 2023, 4:30 PM EDT - 2 years ago

STERIS Raises Dividend to $0.52 per share

Jul 19, 2023, 4:30 PM EDT - 3 years ago

STERIS to Host a Conference Call for Fiscal 2024 First Quarter Financial Results on August 2, 2023

Jun 20, 2023, 8:18 AM EDT - 3 years ago

Steris paying $540 mln for BD surgical instrument unit

BDX

Jun 20, 2023, 8:01 AM EDT - 3 years ago

BD to Sell Surgical Instrumentation Platform to STERIS

BDX

Jun 20, 2023, 8:00 AM EDT - 3 years ago

STERIS Expands Healthcare Products Offering with Acquisition of Surgical Instrumentation Assets from Becton, Dickinson and Company for $540 million

May 10, 2023, 4:30 PM EDT - 3 years ago

STERIS Announces Financial Results for Fiscal 2023 Fourth Quarter and Full Year

ihuntbiggame Apr. 20 at 3:47 PM

2 · Reply

MonkeyPlanet Mar. 27 at 6:10 PM

$STE 🥰

0 · Reply

Ro_Patel Mar. 13 at 2:37 PM

CFRA initiates coverage on $STE & sets TP of $275

0 · Reply

Factozcentral Feb. 23 at 3:05 PM

$SPHR $STE $SSNC $STNG 👁️

0 · Reply

Estimize Feb. 19 at 9:00 PM

Wall St is expecting 2.85 EPS for $STE Q4 [Reporting 05/20 AMC] http://www.estimize.com/intro/ste?chart=historical&metric_name=eps&utm_cont

0 · Reply

ZacksResearch Feb. 5 at 3:01 PM

0 · Reply

ZacksResearch Feb. 5 at 2:01 PM

0 · Reply

StocktwitsEarnings Feb. 5 at 12:00 PM

0 · Reply

ProtocolPartners Feb. 4 at 11:30 AM

$STE is a diversified healthcare product company; its procedure kit business provides steady recurring revenue.

0 · Reply

ZacksResearch Feb. 3 at 1:03 PM

0 · Reply

BillionerOfKing Jan. 30 at 2:34 PM

$STE Current Stock Price: $259.56 Contracts to trade: $260 STE Feb 20 2026 Call Entry: $8.75 Exit: $15.52 ROI: 77% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

ZacksResearch Jan. 28 at 12:31 PM

$STE set to reveal Q3 fiscal 2026 results on Feb. 4! 📊 The Zacks Consensus Estimate pegs revenue at $1.48B, up 8% from the year-ago reported figure, and EPS at $2.53, a 9.1% increase. With a Zacks Rank #3 and Earnings ESP of 0.00%, eyes are on Healthcare capital equipment and AST segments for robust growth. Get the full preview here 👉 https://www.zacks.com/stock/news/2824025/steris-q3-earnings-on-deck-whats-in-store-for-the-stock?cid=sm-stocktwits-2-2824025-body-30584&ADID=SYND_STOCKTWITS_TWEET_2_2824025_BODY_30584

0 · Reply

ZacksResearch Jan. 28 at 11:31 AM

$STE earnings coming up — is the market underestimating this setup? 👀 STERIS enters Q3 with revenues seen up 8% to $1.48B and EPS expected to rise 9.1% to $2.53, supported by strength across Healthcare, AST and Life Sciences. Will these trends be enough to move the stock post-earnings? Find out what’s in store 👉 https://www.zacks.com/stock/news/2824025/steris-q3-earnings-on-deck-whats-in-store-for-the-stock?cid=sm-stocktwits-2-2824025-teaser-30583&ADID=SYND_STOCKTWITS_TWEET_2_2824025_TEASER_30583

0 · Reply

BillionerOfKing Jan. 14 at 6:30 PM

$STE Current Stock Price: $262.13 Contracts to trade: $260 STE Jan 16 2026 Call Entry: $1.10 Exit: $2.11 ROI: 92% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

ZacksResearch Jan. 9 at 4:22 PM

Is now the time to add $STE to your portfolio? 👀 Strong Healthcare and AST growth, solid margins, and balance sheet strength are supporting the story — even as macro pressures and competition remain real risks. See if the risk/reward makes sense here 👉 https://www.zacks.com/stock/news/2814907/is-it-the-right-time-to-add-steris-stock-to-your-portfolio?cid=sm-stocktwits-2-2814907-teaser-28202&ADID=SYND_STOCKTWITS_TWEET_2_2814907_TEASER_28202

0 · Reply

ZacksResearch Jan. 9 at 3:22 PM

$STE up 26.7% in a year — what's driving the gains? 🚀 🩺 Strong adoption in Healthcare fuels growth 🔬 AST division sees 10% growth year over year, driven by a 13% increase in service revenues 💰 Solid financials with an impressive 3.9% earnings yield Discover why STERIS is a Zacks Rank #2 (Buy) and how it's outpacing the industry here 👉 https://www.zacks.com/stock/news/2814907/is-it-the-right-time-to-add-steris-stock-to-your-portfolio?cid=sm-stocktwits-2-2814907-body-28201&ADID=SYND_STOCKTWITS_TWEET_2_2814907_BODY_28201

0 · Reply

jewell69 Jan. 2 at 2:49 PM

$STE RE-ENTRY. CNBC TV GUEST RECC 12/11/25. B 1/2/26 9:45 AM EST. 29 at 251.50. last 4 earns: adds up to 7.01 makes for 35x 1% divvy Ireland based but not in $EIRL 12th largest $IHI

0 · Reply

jewell69 Dec. 24 at 4:13 PM

I'll tell you what my granddaughter's boss told her "You're turning out 2 b a big disappointment in her job at $SBUX " ditto $IYC partial profit. whatever happened to the K economy. Symbol IYC Symbol description ISHARES TR US CONSUM DISCRE Type Cash Shares -79.000 Price $104.67 Amount $8,268.54 blew out of $STE also: I forgot where I got this idea. at least I didn't lose

0 · Reply

JackDarwin Dec. 20 at 9:45 AM

$STE Bullish Engulfing Candlestick Pattern Formed at Downtrend. Wait for the confirmation from the next day's candle.

0 · Reply

jewell69 Dec. 11 at 3:44 PM

$STE 10:41 am EST Thursday trying to buy7 at 255.44 Now in the mid 256’s

0 · Reply

Market Cap	21.92B
Revenue (ttm)	5.46B
Net Income (ttm)	614.64M
EPS (ttm)	N/A
PE Ratio	22.18
Forward PE	20.25
Profit Margin	11.26%
Debt to Equity Ratio	0.26

Volume	446,800
Avg Vol	819,758
Day's Range	N/A - N/A
Shares Out	98.08M
Stochastic %K	37%
Beta	1.07
Analysts	Strong Sell
Price Target	$287.33